Monday, December 9, 2019

Monday, December 9, 2019

Latest News

U.S. FDA: Statement on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses

Statement from Acting FDA Commissioner Ned Sharpless, M.D., on consumer warning to stop using THC vaping products amid ongoing investigation into lung illnesses

AMERICAN COLLEGE OF CHEST PHYSICIANS: Smokers have more blood clots in the lung, leading to higher hospital readmission rates

Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than nonsmokers, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West in New York City, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

REED HUABO EXHIBITIONS: Great Success at 2019 China (Shenzhen) International Vape Expo

From August 29-31, 2019 China (Shenzhen) International Vape Expo, known as RHBVE, has been held by Reed Huabo Exhibition. During the three days, there were over 150 vape brands exhibiting at the show, attracting thousands of E-cig distributors, wholesalers, vape stores, traders, retailers, E-commerce, Tobacco companies, gift company etc. from 23 countries or area over the world.

U.S. FDA: Grants first-ever modified risk orders to eight smokeless tobacco products

The U.S. Food and Drug Administration announced today that, for the first time, it has authorized the marketing of products through the modified risk tobacco product (MRTP) pathway.

SWEDISH MATCH: FDA Designates General Snus as Less Harmful Alternative to Cigarettes

FDA Authorizes Company to State that Use of General Snus Instead of Cigarettes Puts Users at a Lower Risk of Mouth Cancer, Heart Disease, Lung Cancer, Stroke, Emphysema and Chronic Bronchitis

ACHIEVE LIFE SCIENCES: Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.

AROMA BIT: Secures 350mn JPY in Series A Funding from Japan Tobacco and East Ventures

Aroma Bit, Inc. (Representative Director & CEO: Shunichiro Kuroki, headquarters: Chuo-ku, Tokyo, hereinafter "Aroma Bit"), a company which plans and develops compact odor imaging sensors and innovative services using these sensors, has undertaken an third-party allocation of new shares, up to 350 million yen in total, with Japan Tobacco Inc.

SOUTHEAST ASIA TOBACCO CONTROL ALLIANCE: Philippines: LTFRB reiterates ban on smoking in PUVs

The Land Transportation Franchising and Regulatory Board (LTFRB), heeding the directive of the Department of Health (DOH), has reiterated its ban on smoking cigarettes and e-cigarettes in public utility vehicles (PUVs) amid reports of exploding vaping devices.

Tobacco News Wire